Hadassah

Hadassah Cardiologist is Key Researcher in Identifying Genetic Heart Mutation

Tuesday, Sep 1 2015

"Some 2.4 percent of the population suffers from mitral valve prolapse, where one of the valves that controls blood flow through the heart doesn't close properly,” reports Dr. Durst.

Dr. Ronen Durst, a senior cardiologist at the Hadassah Medical Organization and a Hebrew University researcher, is a key member of the international team that has identified a genetic mutation linked to mitral valve prolapse.

Dr. Durst is the first author of the article about this genetic mutation published in the prestigious British science journal, Nature.

The international collaborative research team, led by Massachusetts General Hospital (MGH), where Durst was working in the Center for Human Genetic Research and the Division of Cardiology, had been seeking a genetic connection to this common cardiac problem, which often runs in families. The research led to the discovery of the mutation in the DCHS1 gene in affected members of three families.

"Some 2.4 percent of the population suffers from mitral valve prolapse, where one of the valves that controls blood flow through the heart doesn't close properly,” reports Dr. Durst. “This abnormality,” he brings out, “often causes serious problems in heart rhythm, infections, and even sudden death.”

Dr. Robert Levine of MGH’s Corrigan Minehan Heart Center, co-senior author of the Nature paper, notes: “This finding can teach us how to prevent this inborn disease from manifesting as an illness in people who inherit mutated forms of the gene. Understanding how defects in this gene cause errors in early valve formation can point to ways we can prevent the progression of this condition to keep the valve and the heart healthy and help the patient avoid complications.”

Nature's acceptance of this study, Dr. Durst says, “underlines its international importance and strengthens the link between researchers at Hadassah Hospital and the Hebrew University of Jerusalem with colleagues in prestigious laboratories abroad, such as Harvard and the hospitals with which it is affiliated.”

Comments

From: dvasha on September 10, 2015
pls email this article to me and how I can stay aware of significant developments. Tx.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Jun 22 2018

To Save Their Children - The Mothers Came Secretly From Syria to Hadassah

Repairing the Hearts of Syrian Children at Hadassah Hospital in Jerusalem.

READ MORE ›
alt_text

Thursday, Jun 21 2018

Traveling with Ruth

Ruth Radiano, Head Nurse at Hadassah Hospital Mount Scopus, is an extraordinary woman, whose resume reads like a novel. I recently had the distinct pleasure of meeting her and hearing her speak, and in just five minutes with her, I felt as though I was with a Hadassah sister.

READ MORE ›
alt_text

Wednesday, Jun 20 2018

First in Israel: Hadassah Uses Innovative Technology to Treat Cancer in Spine

A multidisciplinary team at Hadassah Hospital Ein Kerem recently employed an innovative technology to treat cancer metastases near the spinal cord--a first for Israel.

READ MORE ›
alt_text

Tuesday, Jun 19 2018

American Journal of Ophthalmology Article Celebrates the Centennial of Hadassah Ophthalmology

The centennial anniversary of the Hadassah Medical Organization's Department of Ophthalmology is celebrated in the May issue of the American Journal of Ophthalmology, with an article by the immediate past director, Prof. Jacob Pe'er, and the current director, Prof. Itay Chowers.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More